Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China
· Delayed Price · Currency is CNY 30.50
-0.45 (-1.45%)
Mar 9, 2026, 4:00 PM EDT
SHE:301108 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 3,433 | 2,070 | 2,805 | 2,742 | 4,886 | - | Upgrade
|
| Market Cap Growth | 61.31% | -26.20% | 2.31% | -43.89% | - | - | Upgrade
|
| Enterprise Value | 2,365 | 782 | 2,061 | 1,220 | 4,583 | - | Upgrade
|
| Last Close Price | 30.50 | 18.28 | 24.19 | 23.31 | 40.75 | - | Upgrade
|
| PE Ratio | 79.86 | 106.36 | 24.35 | 19.45 | 22.21 | - | Upgrade
|
| Forward PE | 15.72 | 14.31 | 19.19 | 15.76 | - | - | Upgrade
|
| PS Ratio | 4.87 | 3.78 | 4.51 | 4.11 | 4.96 | - | Upgrade
|
| PB Ratio | 1.83 | 1.13 | 1.51 | 1.54 | 2.89 | - | Upgrade
|
| P/TBV Ratio | 1.87 | 1.16 | 1.54 | 1.57 | 2.94 | - | Upgrade
|
| P/FCF Ratio | - | - | - | 10.19 | 38.30 | - | Upgrade
|
| P/OCF Ratio | - | 27.56 | 33.59 | 9.17 | 24.41 | - | Upgrade
|
| EV/Sales Ratio | 3.36 | 1.43 | 3.31 | 1.83 | 4.66 | - | Upgrade
|
| EV/EBITDA Ratio | 20.42 | 12.49 | 15.34 | 7.21 | 16.85 | - | Upgrade
|
| EV/EBIT Ratio | 39.44 | 42.00 | 20.08 | 9.06 | 18.84 | - | Upgrade
|
| EV/FCF Ratio | -10.14 | - | - | 4.53 | 35.92 | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 0.29 | 0.13 | 0.13 | 0.19 | 0.15 | 0.22 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.12 | 0.31 | 0.60 | Upgrade
|
| Net Debt / Equity Ratio | -0.57 | -0.81 | -0.71 | -0.72 | -0.81 | -0.61 | Upgrade
|
| Net Debt / EBITDA Ratio | -9.43 | -23.68 | -9.84 | -7.53 | -5.06 | -1.19 | Upgrade
|
| Net Debt / FCF Ratio | 4.58 | 70.26 | 859.92 | -4.73 | -10.78 | -3.21 | Upgrade
|
| Asset Turnover | 0.32 | 0.26 | 0.30 | 0.32 | 0.68 | 1.19 | Upgrade
|
| Inventory Turnover | 6.08 | 6.14 | 6.65 | 4.47 | 5.48 | 6.96 | Upgrade
|
| Quick Ratio | 4.69 | 7.69 | 6.26 | 6.12 | 5.45 | 1.27 | Upgrade
|
| Current Ratio | 5.56 | 8.09 | 6.56 | 6.42 | 5.98 | 1.58 | Upgrade
|
| Return on Equity (ROE) | 2.82% | 1.04% | 6.30% | 8.12% | 20.61% | 50.91% | Upgrade
|
| Return on Assets (ROA) | 1.71% | 0.55% | 3.04% | 4.09% | 10.45% | 21.01% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.03% | 3.23% | 16.70% | 28.44% | 87.07% | 120.76% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.10% | 1.00% | 5.40% | 7.40% | 13.80% | 44.30% | Upgrade
|
| Earnings Yield | 1.53% | 0.94% | 4.11% | 5.14% | 4.50% | - | Upgrade
|
| FCF Yield | -6.79% | -1.02% | -0.06% | 9.81% | 2.61% | - | Upgrade
|
| Dividend Yield | 0.33% | 0.39% | 1.06% | 1.53% | 1.31% | - | Upgrade
|
| Payout Ratio | 36.62% | 149.83% | 35.25% | 43.21% | 0.12% | 1.69% | Upgrade
|
| Buyback Yield / Dilution | -55.65% | 0.01% | -0.14% | -29.59% | -2.66% | -0.12% | Upgrade
|
| Total Shareholder Return | -55.33% | 0.40% | 0.92% | -28.06% | -1.34% | -0.12% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.